AKT1 and Cerebral ischemia: Met activates the PI3K/Akt signaling pathway, inhibits inflammation, oxidative stress, and apoptosis, increases the actity of BV2 cells, and promotes PI3K phosphorylation to improve neurological deficit symptoms of cerebral ischemia and reperfuion.